This Article Full Text Full Text (PDF) All Versions of this Article: 114/23/2508    most recent CIRCULATIONAHA.106.651117v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by George, J. Articles by Struthers, A. Search for Related Content PubMed PubMed Citation Articles by George, J. Articles by Struthers, A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ALLOPURINOL ASCORBIC ACID PROBENECID SODIUM ASCORBATE Related Collections Other heart failure Cardiovascular Pharmacology Oxidant stress Endothelium/vascular type/nitric oxide

(Circulation. 2006;114:2508-2516.)
© 2006 American Heart Association, Inc.

Vascular Medicine

High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid

Jacob George, MBChB, MRCP; Elaine Carr, RGN, BN; Justine Davies, MD, MRCP; J.J.F. Belch, MD, FRCP; Allan Struthers, MD, FRCP, FESC

From the Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee, UK.

Correspondence to A.D. Struthers, MD, FRCP, FESC, Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. E-mail a.d.struthers{at}dundee.ac.uk

Received July 24, 2006; revision received September 26, 2006; accepted September 28, 2006.

Background— Allopurinol has been shown to improve endothelial function in chronic heart failure. This study aimed to establish its mechanism of action and to construct a dose–response curve for the effect of allopurinol.

Methods and Results— Two randomized, placebo-controlled, double-blind, crossover studies were performed for 1 month on patients with New York Heart Association Class II–III chronic heart failure, comparing 300 mg allopurinol, 600 mg allopurinol, and placebo for the first study and 1000 mg probenecid versus placebo in the second study. Endothelial function was assessed by standard forearm venous occlusion plethysmography. Allopurinol 600 mg/d significantly increased forearm blood flow response to acetylcholine compared with both allopurinol 300 mg/d and placebo (% change in forearm blood flow [mean±SEM]: 240.31±38.19% versus 152.10±18.21% versus 73.96±10.29%, P<0.001). For similar levels of urate lowering, the uricosuric agent probenecid had no effect on endothelial function. Sodium nitroprusside response was unchanged by all treatments. Vitamin C and acetylcholine coinfusion data showed that 600 mg/d allopurinol completely abolished the oxidative stress that was sensitive to high-dose vitamin C.

Conclusions— For the first time, we have shown that a steep dose–response relationship exists between allopurinol and its effect on endothelial function. We also showed that the mechanism of improvement in endothelial function with allopurinol lies in its ability to reduce vascular oxidative stress and not in urate reduction. The reduction in vascular oxidative stress was profound because high-dose allopurinol totally abolished the oxidative stress that was sensitive to the high-dose vitamin C that was used in this study.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				J. Dawson, T. J. Quinn, and M. R. Walters Response to Letter by Proctor Stroke, May 1, 2008; 39(5): e89 - e89. [Full Text] [PDF]

				H. K. Choi and G. Curhan Independent Impact of Gout on Mortality and Risk for Coronary Heart Disease Circulation, August 21, 2007; 116(8): 894 - 900. [Abstract] [Full Text] [PDF]

				J. T. Kielstein, A. Woywodt, and S. R. Salpeter Letter by Kielstein et al Regarding Article, "High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid" Circulation, May 8, 2007; 115(18): e450 - e451. [Full Text] [PDF]

				J. George, E. Carr, J. Davies, J.J.F. Belch, and A. Struthers Response to Letter Regarding Article, "High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid" Circulation, May 8, 2007; 115(18): e451 - e451. [Full Text] [PDF]

				L. O. Lerman and A. Lerman All Oxidase Roads Lead to Angiotensin, Too Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 703 - 704. [Full Text] [PDF]